89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
14.87
-0.09 (-0.60%)
At close: Sep 19, 2025, 4:00 PM EDT
14.88
+0.01 (0.07%)
After-hours: Sep 19, 2025, 7:58 PM EDT
89bio Employees
89bio had 93 employees as of December 31, 2024. The number of employees increased by 23 or 32.86% compared to the previous year.
Employees
93
Change (1Y)
23
Growth (1Y)
32.86%
Revenue / Employee
n/a
Profits / Employee
-$4,840,925
Market Cap
2.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 93 | 23 | 32.86% |
| Dec 31, 2023 | 70 | 25 | 55.56% |
| Dec 31, 2022 | 45 | 4 | 9.76% |
| Dec 31, 2021 | 41 | 14 | 51.85% |
| Dec 31, 2020 | 27 | 7 | 35.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ETNB News
- 1 day ago - 3 Potential Biotech Acquisition Targets - Seeking Alpha
- 1 day ago - 89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB - Business Wire
- 2 days ago - Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push - Benzinga
- 2 days ago - Top 2 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 2 days ago - Roche to Buy 89bio for Up to $3.5 Billion - WSJ
- 2 days ago - Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
- 2 days ago - 89bio, Inc. Announces Agreement to be Acquired by Roche - GlobeNewsWire
- 11 days ago - 89bio, Inc. (ETNB) Presents At Cantor Global Healthcare Conference 2025 (Transcript) - Seeking Alpha